Skip to Content

The headlines

Help test a new questionnaire
Poster Psoriasis And Psoriatic Arthritis
Help test a new questionnaire

A person's psoriasis or psoriatic arthritis can affect the lives of partners and family members, but this important impact is often ignored.

New grant call gives a boost to autoimmune research
IG Card For Patients Public (Less Text)
New grant call gives a boost to autoimmune research

PAPAA working through our Connect Immune Research partnership, is excited to be part of an innovative new grant call...

Top Ten Psoriatic Arthritis Research Priorities
Psa PSP Top 10
Top Ten Psoriatic Arthritis Research Priorities

The British Psoriatic Arthritis Consortium (BritPACT) worked with the James Lind Alliance (JLA) to run a priority setting partnership (PSP). They have created a national top 10 list of research priorities for psoriatic arthritis, agreed upon by people with psoriatic arthritis, carers and clinicians. This marks the culmination of the psoriasis arthritis PSP.

 

Connect Immune Research group expands
Connect Immune Research
Connect Immune Research group expands

Bowel Research UK has joined the Connect Immune Research initiative, which includes the type 1 diabetes charity JDRF, the MS Society, Versus Arthritis, the British Society for Immunology, Alopecia UK, the Psoriasis and Psoriatic Arthritis Alliance (PAPAA) and Coeliac UK.

Latest journal now available
Psoriasis And And Psoriatic Arthritis Patient Magazine
Latest journal now available

Skin 'n' Bones Connection issue 53 is now available. The journal is aimed at people affected by psoriasis and psoriatic arthritis.

Guselkumab recommended by NICE
Psoriatic arthritis hands.jpg
Guselkumab recommended by NICE

Guselkumab (Tremfya), taken with or without methotrexate, has been recommended by the National Institute for Health and Care Excellence (NICE) and is available on the NHS.

Care, Cause, Cure: the PAPAA vision
Donate To Psoriasis And Psoriatic Arthritis Research
Care, Cause, Cure: the PAPAA vision

See our new video that is part of our strategy to raise awareness of psoriasis and psoriatic arthritis and includes our mission to look and delve deeper into the causes of psoriatic disease by funding research projects. 

Co-codamol 30/500 Effervescent Tablets recalled
MHRA Drug Recall
Co-codamol 30/500 Effervescent Tablets recalled

People who use Co-codamol 30/500 Effervescent Tablets, widely used for pain relief, are today being asked to check the batch number on the labels of packs to ensure they are not one of 4,464 packs which are being recalled due to safety concerns.

Psoriasis in Practice course fully updated
Psoriasis In Practice Elearning
Psoriasis in Practice course fully updated

The new version 7 of PAPAA's popular Psoriasis in Practice digital resource online training programme is now available until 29 April 2022.  The programme is aimed at helping frontline healthcare providers to manage and care for people affected by the skin condition psoriasis, and its associated psoriatic arthritis.

FREE online 8-week intervention
Chronic Pain Survey Psoriatic Arthritis
FREE online 8-week intervention

Are you aged 18 or over and living with chronic pain? Are you interested in taking part in a FREE online 8-week intervention?  

This is research project being carried out by a Masters student, if you are interested, read the full request.

Show more